Researchers at Tomsk Polytechnic University are developing a technology for controlling mesenchymal stem cells for more effective cancer treatment. They suggested using the patient's own cells connected to magnets, which, firstly, excludes rejection and, secondly, helps to deliver the medicine directly to the focus of the disease.
The development of magnetic cell technology is a joint project of TPU, St. Pavlov and Queen Mary University of London.
Capture of magnetic microcapsules by mesenchymal cells
In mesenchymal stem cells 10 microns in size, magnetized capsules containing the drug are implanted. With the help of external synchronization through the magnets, the capsules reach the affected cells, where they open, releasing the drug. This achieves a "precise hit" in cancer cells without damaging healthy ones.